Product
Tablets
1 clinical trial
6 indications
Indication
Community-acquired PneumoniaIndication
SepsisIndication
Inflammatory ResponseIndication
MortalityIndication
BiomarkersIndication
systemic inflammatory response syndromeClinical trial
A Randomized Clinical Trial of Oral Clarithromycin in Community-acquired Pneumonia to Attenuate Inflammatory Responses and Improve Outcomes: the ACCESS Clinical TrialStatus: Completed, Estimated PCD: 2023-04-11